期刊文献+

丙肝病毒核心蛋白对肝门部胆管癌细胞增殖和细胞凋亡的调控作用 被引量:5

Hepatitis C virus core protein modulating proliferation and apoptosis of hilar cholangiocarcinoma tissues
原文传递
导出
摘要 目的 探讨丙肝病毒核心蛋白 (HCVC蛋白 )在肝门部胆管癌发生和发展中的作用。方法 采用过氧化物酶 抗过氧化酶 (PAP)法检测 36例肝门部胆管癌组织中HCVC蛋白的表达 ,原位末端标记技术 (ISEL)和链霉亲合素 生物素技术 (SLAB)分别检测肝门部胆管癌中的细胞凋亡指数 (AI)和细胞增殖指数 (PI)。结果  36例肝门部胆管癌患者中HCVC蛋白阳性表达率为61 .1 % (2 2 /36) ,AI和PI的平均值分别为 (3 .46± 0 .62 ) %和 (46 .43± 1 2 .59) % ,HCVC蛋白阳性表达组中AI明显低于HCVC蛋白阴性表达组 (P <0 .0 1 ) ,而PI在HCVC蛋白阳性组中明显高于HCVC蛋白阴性组 (P <0 .0 1 )。结论 HCVC蛋白可能有助于肝门部胆管癌细胞增殖 。 Objective To explore the role of hepatitis C virus core protein in the development of hilar cholangiocarcinoma tissues.Methods Thirty cases of surgical specimens from hilar cholangiocarcinoma were studied by immunohistochemical staining for hepatitis C virus core protein (HCV C protein) and PCNA index (PI). In situ end labeling and immunohistological SLAB methods were used to detect aopototic index (AI) and PI in hilar cholangiocarcinoma.Results The positive expression of HCV C protein in the patients with hilar cholangiocarcinoma was 61.6% (22/36). The mean values of AI and PI were (3.46±0.62)% and (46.43±12.59)% respectively. PI in hilar cholangiocarcinoma tissues positive for HCV C protein was significantly higher than those negative for HCV antigen (P<0.01),while AI in the hilar cholangiocarcinoma tissues positive for HCV C protein was significantly lower than those negative for HCV C protein (P<0.01).Conclusion HVC C protein may contribute to hilar cholangiocarcinoma proliferation and reduce apoptosis of hilar cholangiocarcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2002年第6期510-511,I001,共3页 Chinese Journal of Experimental Surgery
基金 中国博士后基金资助项目 [中博基 ( 2 0 0 2 ) 16号 ]
关键词 丙肝病毒核心蛋白 胆管癌 细胞增殖 细胞凋亡 调控作用 Cholangiocarcinoma Hepatitis C virus Proliferation Apoptosis
  • 相关文献

参考文献3

二级参考文献4

共引文献7

同被引文献34

  • 1黎洪浩,王捷,段朝晖,张红卫,陈积圣.干扰素联合肝动脉化疗栓塞和门静脉化疗对预防肝癌切除术后复发的价值[J].中华肿瘤杂志,2004,26(9):558-561. 被引量:12
  • 2张志培,程庆书,黄立军,徐鉷,王文勇,王小平.HCVC蛋白、p53、Mdm2、p14和p21在原发性肝癌中的表达及相关性[J].现代肿瘤医学,2006,14(10):1252-1255. 被引量:3
  • 3Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol,2003,15:740-746.
  • 4Huber MA, Kraut N, Beug H. Molecular requirements for epithelialmesenchymal transition during tumor progression. Current Opinion in Cell Biology ,2005,17:548-558.
  • 5刘丽君,魏来.丙型肝炎病毒的流行病学[J].传染病信息,2007,20(5):261-264. 被引量:72
  • 6Giannini C,Brechot C.Hepatitis C virus biology[J].Cell Death Differ,2003,10 Suppl 1:27-38.
  • 7Pybus OG,Barnes E,Taggart R,et al.Genetic history of hepatitis C virus in East Asia[J].J Virol,2009,83(2):1071-1082.
  • 8Zaltron S,Spinetti A,Biasi L,et al.Chronic HCV infection:epidemiological and clinical relevance[J].BMC Infect Dis,2012,12 Suppl2:S2.
  • 9Strader DB,Wright T,Thomas DL,et al.Diagnosis,management,and treatment of hepatitis C[J].Hepatology,2004,39(4):1147-1171.
  • 10Francisci D,Valente M,Di Candilo F,et al.Epidemiological,clinical andtherapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients[J].Recenti Prog Med,2004,95(11):521-524.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部